CasLoc logo
All Cases PTAB Litigations UPC Oppositions

GlaxoSmithKline LLC v. Banner Pharmacaps Inc.

1:11-cv-00046

Overview

Case Number 1:11-cv-00046
Filing Date 2011-01-12
Status Terminated
Termination Date 2013-08-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Roxane Laboratories Inc. Operating Company

Represented By

4 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Darryl H. Steensma

Email: darryl.steensma@lw.com

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Marc N. Zubick

Email: marc.zubick@lw.com

Anchen Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Anchen Inc. Operating Company

Represented By

2 Attorneys Listed

Watson Laboratories Inc. - Florida Operating Company

Represented By

8 Attorneys Listed

Jason James Rawnsley

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7550

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Robyn H. Ast-Gmoser

Email: rast@polsinelli.com

Mark T. Deming

Email: mdeming@polsinelli.com

Karen M. Zelle

Email: kzelle@polsinelli.com

Jonathan Morgan Kirley

Email: mkirley@polsinelli.com

Graham L. Day

Email: gday@polsinelli.com

Banner Pharmacaps Inc. Operating Company

Represented By

1 Attorneys Listed

Impax Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Mylan Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

GlaxoSmithKline LLC NPE (University / Research)

Represented By

2 Attorneys Listed

Counter Claimant

Watson Pharma Inc. Operating Company

Represented By

3 Attorneys Listed

Jason James Rawnsley

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7550

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Gary E. Hood

Email: ghood@polsinelli.com

Watson Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Jason James Rawnsley

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7550

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Mylan Inc. Operating Company

Represented By

5 Attorneys Listed

James H. Wallace , Jr.

Email: jwallace@wileyrein.com

Mark A. Pacella

Email: mpacella@wileyrein.com

Lucy Stark

UNDELIVERABLE EMAIL 1/221/5

Gregory Lyons

Email: glyons@wileyrein.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2012-08-31
1:12-cv-01090

GlaxoSmithKline LLC v. Apotex Inc.

U.S. Family Sibling (["US5565467"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5565467
Androstenone derivative
Filed: 1995-03-16
Issued: 1996-10-15
Expired (Term Ended) +249d PTA
Expires: 2015-11-20
US5846976
Androstenone derivative
Filed: 1996-08-22
Issued: 1998-12-08
Expired (Term Ended)
Expires: 2016-08-22
US5998427
Androstenones
Filed: 1998-05-14
Issued: 1999-12-07
Expired (Term Ended)
Expires: 2018-05-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+249 days) / Cellect Scrutiny — Over 249 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

21

Dispositive

0

Granted

0

Denied

1

Pending / Review

20

Motions by Category

Claim Construction / Markman Filing 15 Procedural / Extension Motion 3 Motion to Strike / Sanctions 3

Key Dispositive Motions & Rulings

Motion to Strike / Sanctions Pending / Under Review
REDACTED VERSION of 274 MOTION to Strike the Supplemental Reports of GSK's Experts by Roxane Laboratories Inc.. (Moore, David) (Entered: 02/01/2013)
Entry #277 • 2013-02-01 Document →
Motion to Strike / Sanctions Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 274 MOTION to Strike the Supplemental Reports of GSK's Experts, filed by GlaxoSmithKline LLC.Reply Brief due date per ...
Entry #275 • 2013-01-27 Document →
Motion to Strike / Sanctions Pending / Under Review
[SEALED] MOTION to Strike the Supplemental Reports of GSK's Experts - filed by Roxane Laboratories Inc.. (Attachments: # 1 Exhibits A-D)(Moore, David) Modified ...
Entry #274 • 2013-01-25 Document →
Claim Construction / Markman Filing Pending / Under Review
Claim Construction OPINION. Signed by Judge Richard G. Andrews on 11/15/2012. (nms)
Entry #243 • 2012-11-15 Document →
Claim Construction / Markman Filing Pending / Under Review
Official Transcript of Markman Hearing held on 09-04-12 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed a...
Entry #226 • 2012-09-10 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION And Order to Extend Time for Plaintiff to Oppose 215 Motion to Exclude Opinions and Testimony of Dr. Stephen Byrn, by Anchen Inc., Anchen Pharmaceut...
Entry #225 • 2012-09-07 Document →

Docket Entries

(329 total)
Pleading / Complaint

COMPLAINT filed against Anchen Inc., Anchen Pharmaceuticals Inc., Banner Pharmacaps Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-832877.) - filed by GlaxoSmithKline LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(ksr) (Entered: 01/13/2011)

Entry #1 • 2011-01-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (ksr) (Entered: 01/13/2011)

Entry #2 • 2011-01-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,565,467; 5,846,976; 5,998,427;. (ksr) (Entered: 01/13/2011)

Entry #3 • 2011-01-12
1

Disclosure Statement pursuant to Rule 7.1 filed by GlaxoSmithKline LLC identifying Corporate Parent GlaxoSmithKline plc. for GlaxoSmithKline LLC. (ksr) (Entered: 01/13/2011)

Entry #4 • 2011-01-12
1
Pleading / Complaint

SUMMONS Returned Executed by GlaxoSmithKline LLC. Anchen Inc. served on 1/14/2011, answer due 2/4/2011. (Blumenfeld, Jack) (Entered: 01/18/2011)

Entry #5 • 2011-01-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc